Dr AUVRAY received his PhD of Pharmacology, Cell and Molecular
in 1998 from the University of Caen, France. The fields of his
research in this CNRS Unit were the Hormonotherapy of breast cancer,
especially the development of new antisens compounds against the
Dr AUVRAY, in collaboration with INSERM unit U.625 developed
technology in transgenesis, based on the genetic modification of
genome. This technology is now exploited in the French society
Dr AUVRAY has a large
experience in preclinical development of drugs.
He previously worked in
a Biotechnology society for four years where he developed the Molecular
Biology, Hormonotherapy and Gene Therapy
unit. He became then the head
of this department.
In this society, Dr AUVRAY acted as preclinical advisor to pharmaceutical development companies.
developed R&D programs in the fields of Molecular Biology,
especially with an European Project that led to identification of new